Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones

NCT03007147 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT03007147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03007147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 8, 2017
Completion date
September 30, 2034
Enrollment
352 (actual)
Sites
226

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, b acute lymphoblastic leukemia, mixed phenotype acute leukemia, t acute lymphoblastic leukemia